These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18614446)

  • 1. Correlates of insider and outsider conceptualizations of recovery.
    Brown C; Rempfer M; Hamera E
    Psychiatr Rehabil J; 2008; 32(1):23-31. PubMed ID: 18614446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The construct validity of empowerment among consumers of mental health services.
    Corrigan PW; Faber D; Rashid F; Leary M
    Schizophr Res; 1999 Jul; 38(1):77-84. PubMed ID: 10427613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding how clinician-patient relationships and relational continuity of care affect recovery from serious mental illness: STARS study results.
    Green CA; Polen MR; Janoff SL; Castleton DK; Wisdom JP; Vuckovic N; Perrin NA; Paulson RI; Oken SL
    Psychiatr Rehabil J; 2008; 32(1):9-22. PubMed ID: 18614445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assertive community treatment in the Netherlands: a randomized controlled trial.
    Sytema S; Wunderink L; Bloemers W; Roorda L; Wiersma D
    Acta Psychiatr Scand; 2007 Aug; 116(2):105-12. PubMed ID: 17650271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological prognosis and clinical recovery.
    Silverstein ML; Harrow M; Bryson GJ
    Psychiatry Res; 1994 Jun; 52(3):265-72. PubMed ID: 7991720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of an illness self-management group using wellness recovery action planning.
    Starnino VR; Mariscal S; Holter MC; Davidson LJ; Cook KS; Fukui S; Rapp CA
    Psychiatr Rehabil J; 2010; 34(1):57-60. PubMed ID: 20615846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological abnormalities in schizophrenia and major mood disorders: similarities and differences.
    Barch DM
    Curr Psychiatry Rep; 2009 Aug; 11(4):313-9. PubMed ID: 19635240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychometric differentiation of schizophrenic and schizoaffective psychoses].
    Bühler KE; Gross M; Jürgensen R
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(6):535-52. PubMed ID: 1722906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal relationships between neurocognition, theory of mind, and community functioning in outpatients with serious mental illness.
    Cook EA; Liu NH; Tarasenko M; Davidson CA; Spaulding WD
    J Nerv Ment Dis; 2013 Sep; 201(9):786-94. PubMed ID: 23995035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Brissos S; Dias VV; Carita AI; Martinez-Arán A
    Psychiatry Res; 2008 Jul; 160(1):55-62. PubMed ID: 18485488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of long-term outcome of schizophrenic, affective and schizoaffective disorders.
    Marneros A; Deister A; Rohde A
    Br J Psychiatry Suppl; 1992 Oct; (18):44-51. PubMed ID: 1389041
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of active psychosis and first-episode psychosis negative symptoms.
    Lyne J; Joober R; Schmitz N; Lepage M; Malla A
    Early Interv Psychiatry; 2017 Feb; 11(1):63-71. PubMed ID: 25582878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for PTSD in public-sector mental health settings: the diagnostic utility of the PTSD checklist.
    Grubaugh AL; Elhai JD; Cusack KJ; Wells C; Frueh BC
    Depress Anxiety; 2007; 24(2):124-9. PubMed ID: 16892418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and use of the functioning assessment short test in first psychotic episodes.
    González-Ortega I; Rosa A; Alberich S; Barbeito S; Vega P; Echeburúa E; Vieta E; González-Pinto A
    J Nerv Ment Dis; 2010 Nov; 198(11):836-40. PubMed ID: 21048476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Work-ordered day as a catalyst of competitive employment success.
    Schonebaum A; Boyd J
    Psychiatr Rehabil J; 2012 Sep; 35(5):391-5. PubMed ID: 23116381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalizability of brief psychiatric rating scale prototypical profiles and their use in evaluating treatment outcomes.
    Burger GK; Yonker RD; Calsyn RJ; Morse GA; Klinkenberg WD
    Int J Methods Psychiatr Res; 2005; 14(1):56-64. PubMed ID: 16097400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is cognitive enhancement therapy equally effective for patients with schizophrenia and schizoaffective disorder?
    Lewandowski KE; Eack SM; Hogarty SS; Greenwald DP; Keshavan MS
    Schizophr Res; 2011 Feb; 125(2-3):291-4. PubMed ID: 21167689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Object relations and reality testing in schizophrenia, bipolar disorders, and healthy controls: differences in profiles and clinical correlates.
    Hansen CF; Torgalsbøen AK; Røssberg JI; Andreassen OA; Bell MD; Melle I
    Compr Psychiatry; 2012 Nov; 53(8):1200-7. PubMed ID: 22578986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MIRECC version of the Global Assessment of Functioning scale: reliability and validity.
    Niv N; Cohen AN; Sullivan G; Young AS
    Psychiatr Serv; 2007 Apr; 58(4):529-35. PubMed ID: 17412856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.